60 related articles for article (PubMed ID: 1823387)
1. 125I-vasoactive intestinal peptide binding in human kidney.
Charlton BG; Neal DE; Simmons NL
Miner Electrolyte Metab; 1991; 17(6):372-6. PubMed ID: 1823387
[TBL] [Abstract][Full Text] [Related]
2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
4. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
Fouchier F; Forget P; Pic P; Marvaldi J; Pichon J
Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
[TBL] [Abstract][Full Text] [Related]
5. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
Griffiths NM; Simmons NL
Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
[TBL] [Abstract][Full Text] [Related]
6. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
Turner JT; Bylund DB
J Pharmacol Exp Ther; 1987 Sep; 242(3):873-81. PubMed ID: 2821229
[TBL] [Abstract][Full Text] [Related]
8. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
Diehl NL; Kermode JC; Shreeve SM
Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
12. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
Ando E; Nokihara K; Naruse S; Wray V
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
[TBL] [Abstract][Full Text] [Related]
13. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
Carstairs JR; Barnes PJ
J Pharmacol Exp Ther; 1986 Oct; 239(1):249-55. PubMed ID: 3020233
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
15. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J
Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
Griffiths NM; Rugg EL; Simmons NL
Q J Exp Physiol; 1989 May; 74(3):339-53. PubMed ID: 2546173
[TBL] [Abstract][Full Text] [Related]
18. High-affinity binding sites for VIP in renal cortical membranes: possible role of VIP in renal transport.
Kniaz D; Pahlavan P; Valaitis D; Arruda JA
Kidney Int; 1991 Feb; 39(2):266-72. PubMed ID: 1848330
[TBL] [Abstract][Full Text] [Related]
19. An endothelial cell-line contains functional vasoactive intestinal polypeptide receptors: they control inwardly rectifying K+ channels.
Pasyk E; Mao YK; Ahmad S; Shen SH; Daniel EE
Eur J Pharmacol; 1992 Mar; 212(2-3):209-14. PubMed ID: 1318211
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic localisation of VIP receptors in human lung.
Leys K; Morice AH; Madonna O; Sever PS
FEBS Lett; 1986 Apr; 199(2):198-202. PubMed ID: 3009219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
